<bill session="113" type="s" number="2980" updated="2016-10-25T16:32:53Z">
  <state datetime="2014-12-04">REFERRED</state>
  <status>
    <introduced datetime="2014-12-04"/>
  </status>
  <introduced datetime="2014-12-04"/>
  <titles>
    <title type="short" as="introduced">Ensuring Equal Access to Treatments Act of 2014</title>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to modify payment under the Medicare program for outpatient department procedures that utilize drugs as supplies, and for other purposes.</title>
    <title type="display">Ensuring Equal Access to Treatments Act of 2014</title>
  </titles>
  <sponsor bioguide_id="M000639"/>
  <cosponsors>
    <cosponsor bioguide_id="B001135" joined="2014-12-04"/>
    <cosponsor bioguide_id="K000360" joined="2014-12-04"/>
  </cosponsors>
  <actions>
    <action datetime="2014-12-04">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2014-12-04" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="113" relation="unknown" number="4857"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug therapy"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Home and outpatient care"/>
    <term name="Medicare"/>
  </subjects>
  <amendments/>
  <summary date="2014-12-04T05:00:00Z" status="Introduced in Senate">Ensuring Equal Access to Treatments Act of 2014 - Amends title XVIII (Medicare) of the Social Security Act, with respect to the prospective payment system for hospital outpatient department (OPD) services, to direct the Secretary of Health and Human Services (HHS) to create certain additional groups of covered OPD services that classify separately, from those that do not utilize such a drug, procedures that utilize a drug (other than contrast agents and diagnostic radiopharmaceuticals) that both has a cost above the drug packaging threshold and functions as a supply when used in a diagnostic test or procedure.</summary>
  <committee-reports/>
</bill>
